Cooperative Agreement 2025819

This $255,966 National Science Foundation Technology, Innovation, and Partnerships award to Nano-Product Engineering, LLC will support the development of an antiviral/antimicrobial micropowder for application to personal protective equipment and respiratory equipment surfaces. The award period is from September 15, 2022 through May 31, 2023. The project aims to improve the protective properties of commonly used PPE and respiratory equipment, which typically only provides passive protection and...

This $256,000 National Science Foundation Project Grant under the Engineering (47.041) program will support the development of a permanent ceramic antimicrobial coating technology by Nanoionix, LLC. The goal is to synthesize and deposit a pure ceramic coating on relevant substrates that exceeds EPA requirements for generating reactive oxygen species to inactivate viruses and bacteria. Nanoionix will conduct spectroscopic assessments to rapidly evaluate the types and numbers of reactive oxygen...

The National Science Foundation Division of Industrial Innovation awarded a $256,000 Project Grant to Avior Inc., doing business as Avior Bio, to develop a safe and effective copper nanoparticle suspension formulation for face mask applications against SARS-CoV-2 and other viruses. The grant period runs from July 1, 2021 through December 31, 2021 under the Engineering (47.041) federal grant program. Through this funding, Avior Bio will work to produce a nanoparticle formulation that can be...

The National Science Foundation (NSF) awarded a $878,296 Cooperative Agreement to Surfplasma Inc., a minority-owned small business based in Gainesville, FL, to develop a rapid, low-temperature plasma prototype for disinfecting personal protective equipment (PPE), medical devices, food products and other materials from pathogens like COVID-19. The project, funded under NSF's Technology, Innovation, and Partnerships (CFDA 47.084) program, aims to deliver a market-ready sterilization solution...

The National Science Foundation Division of Industrial Innovation awarded Quick-Med Technologies, Inc. a $255,999 Project Grant under the Engineering federal grant program (CFDA 47.041) to develop Regenerable Antimicrobial Paints Based on Hydrogen Peroxide. This award, issued on April 1, 2021 for completion by September 30, 2021, will support Quick-Med Technologies' efforts to improve the quality of life and economic strength of the nation by fostering innovation in engineering research....

Carrisan Technologies Inc. received a $255,990 National Science Foundation Project Grant under the NSF Directorate for Engineering SBIR PHASE I program to develop persistent antimicrobial compositions to prevent cross-contamination via hands and gloves from May 2021 through April 2022. The NSF SBIR PHASE I program aims to support innovative research and development from small businesses and translate promising ideas into products and services with commercial potential or public benefit. Under...

This $249,999 National Science Foundation project grant supports the development of a bioengineered nanobarrier spray to protect against SARS-CoV-2 and other viral infections of the nasopharynx. Funded under the NSF Engineering program (CFDA 47.041), the two-year award to the University of Southern California will support computational modeling of nanobarrier delivery via nasal applicator as well as efficacy testing in a coronavirus mouse model. Specifically, the university researchers will...

This $1,000,000 Cooperative Agreement awarded by the National Science Foundation (NSF) under the Technology, Innovation, and Partnerships (TIP) program (CFDA 47.084) supports research and development efforts by Akanocure Pharmaceuticals Inc. to optimize a novel, broad-spectrum antiviral and immunomodulatory agent for oral administration against coronaviruses. The project focuses on lead optimization, including the design, synthesis, and testing of analogs with improved drug-like properties for...

The National Science Foundation awarded a $255,981 Small Business Innovation Research Phase I Project Grant to Frezent Biological Solutions Inc. of Valhalla, NY under the Engineering (CFDA 47.041) federal grant program. The grant funds the development of a novel peptide inhibitor of the coronavirus papain-like protease as a prophylactic and antiviral therapeutic for COVID-19, to be administered via inhalation. The Engineering program seeks to improve quality of life and economic strength...

The National Science Foundation awarded a $255,961 Small Business Technology Transfer Phase I Project Grant under the NSF Technology, Innovation, and Partnerships program (CFDA 47.084) to Rush River Research Corp. The grant aims to develop a low-cost, automated receptacle for rapid point-of-care sterilization of personal protective equipment, such as filtering facepiece respirators, for frontline healthcare workers during the COVID-19 pandemic. Specifically, the company will construct and...